Effect of Tomato Paste Consumption on the Microbiota-gut-brain Axis in Healthy Adults (MITOS)
Development of Sustainable Tomato Products to Improve the Microbiota-gut-brain Axis: From Farm to Fork to Health (MITOS)
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Rosa M Lamuela Raventós, PhD
- Phone Number: +34-934020909
- Email: lamuela@ub.edu
Study Locations
-
-
-
Barcelona, Spain, 08028
- Department of Nutrition, Food Sciences and Gastronomy. School of Farmacy and Food Sciences. University of Barcelona.
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Healthy adult subjects with BMI < 30 kg/m2
- Signed informed consent
Exclusion Criteria:
- Participants with tomato allergy or intolerance
- Cardiovascular disease (cancer or diabetes)
- Mental disorders (e.g. depression, dementia, autism, etc.)
- Cardiovascular alterations in triglycerides or glucose
- Participants with body mass index (BMI) > 30 kg/m2
- Current smokers
- Frequent use of corticoids, nonsteroidal anti-inflammatory drugs
- Volunteers with extreme eating habits (i.e. Atkins diet, very high protein diets, etc.)
- Excessive alcohol consumption (>30 g/d for males and >20 g/d for females),
- Pregnant or lactating women
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Group AB (intervention / control)
After a 1-week washout period avoiding consumption of tomato, tomato-based products and other food sources of lycopene (watermelon, papaya, grapefruit and lycopene supplements), participants will consume a daily amount of 0.5 g of tomato paste / kg of body weight following the regular diet plus consumption of low to moderate tomato or tomato-based products and lycopene containing foods during 3 months (intervention).
Then they will return to their regular dietary pattern during 3 weeks.
At the beginning of the first 4 month, participants will be encouraged to move into the second phase (control), before a 1-week washout period.
The second phase or control consists in following their regular diet plus consumption of low to moderate tomato or tomato-based products and lycopene containing foods during the next 3 months.
|
Participants will consume a daily amount of 0.5 g of tomato paste / kg of body weight following the regular diet plus consumption of low to moderate tomato or tomato-based products and lycopene containing foods
Participants will consume the regular diet plus consumption of low to moderate tomato or tomato-based products and lycopene containing foods
|
|
Experimental: Group BA (control / intervention)
After a 1-week washout period avoiding consumption of tomato, tomato-based products and other food sources of lycopene (watermelon, papaya, grapefruit, and lycopene supplements), participants will start the control intervention which consists of following their regular diet plus consumption of low to moderate tomato or tomato-based products and lycopene containing foods during 3 months (control).
Then they will return to their regular diet during 3 weeks.
At the beginning of the first 4 month, participants will be encouraged to move into the second phase (intervention), before a 1-week washout period.
The intervention consist in consuming a daily amount of 0.5 g of tomato paste / kg of body weight diet plus consumption of low to moderate tomato or tomato-based products and lycopene containing foods during the next 3 months.
|
Participants will consume a daily amount of 0.5 g of tomato paste / kg of body weight following the regular diet plus consumption of low to moderate tomato or tomato-based products and lycopene containing foods
Participants will consume the regular diet plus consumption of low to moderate tomato or tomato-based products and lycopene containing foods
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in brain-derived neurotrophic factor (BDNF) after each intervention with tomato paste and the control intervention.
Time Frame: Baseline and after completed each intervention (3 months)
|
Serum samples will be analysed for mature BDNF using a Mature BDNF Rapid ELISA kit.
|
Baseline and after completed each intervention (3 months)
|
|
Changes in cognitive function (executive) after each intervention with tomato paste and the control intervention.
Time Frame: Baseline and after completed each intervention (3 months)
|
The Wisconsin Sorting Cards Test (WSCT) will assess strategic planning, organized searching, utilizing environmental feedback to shift cognitive sets, directing behaviour towards achieving a goal and modulating impulsive responding.
|
Baseline and after completed each intervention (3 months)
|
|
Changes in cognitive function (attention) after each intervention with tomato paste and the control intervention.
Time Frame: Baseline and after completed each intervention (3 months)
|
The d2 Test will meausure selective and sustained attention and visual scanning speed.
Processing speed, rule compliance, and quality of performance will be assess in participants.
|
Baseline and after completed each intervention (3 months)
|
|
Changes in cognitive function (memory) after each intervention with tomato paste and the control intervention.
Time Frame: Baseline and after completed each intervention (3 months)
|
The face-name associative memory exam (FNAME) will assess associative memory function.Participants will be asked to remember a set of faces and the names they are paired with.
After a 5-25 minute delay, participants will recall which of the faces and names they saw earlier.
|
Baseline and after completed each intervention (3 months)
|
|
Changes in cerebrovascular function after each intervention with tomato paste and the control intervention.
Time Frame: Baseline and after completed each intervention (3 months)
|
Cerebrovascular function will be measured using functional magnetic resonance imaging (FMRI), a non-invasive method for assessing brain activity.
FMRI maps blood oxygenation levels in the brain and estimates changes in the blood flow that depends on metabolic function and is correlated with specific brain region activities
|
Baseline and after completed each intervention (3 months)
|
|
Changes in the gut microbiota after each intervention with tomato paste and the control intervention.
Time Frame: Baseline and after completed each intervention (3 months)
|
Fecal samples will be collected by the volunteers using a system for easy self-collection and stabilization of microbial DNA for gut microbiome profiling (OMNIgene - GUT).
The genomic DNA will be extracted from fecal samples using the DNeasy PowerSoil Kit.
Then, microbial profiling using 16S ribosomal RNA (rRNA) sequencing will be used to study microbial communities, specially bacterial phylogeny and taxonomy.
|
Baseline and after completed each intervention (3 months)
|
|
Changes in the polyphenols and carotenoids and their metabolites after each intervention with tomato paste and the control intervention.
Time Frame: Baseline and after completed each intervention (3 months)
|
Carotenoids and polyphenols, and their metabolites derived from intestinal gut microbiota will be identified and quantified in human plasma, urine, feces, and saliva samples using High Performance Liquid Chromatography HPLC-LTQ-Orbitrap-MS/MS and HPLC-MS/MS techniques.
|
Baseline and after completed each intervention (3 months)
|
|
Changes in the short-chain fatty acids in plasma and feces samples after each intervention with tomato paste and the control intervention.
Time Frame: Baseline and after completed each intervention (3 months)
|
After acidifying the fecal samples with formic acid, a quantification of short-chain fatty acids will be performed using gas chromatography by direct injection according to previously described methodology (Zhao et al., 2006).
|
Baseline and after completed each intervention (3 months)
|
|
Changes in bile acids in plasma and feces samples after each intervention with tomato paste and the control intervention.
Time Frame: Baseline and after completed each intervention (3 months)
|
Bile acids will be assayed using a validated liquid chromatography-mass spectrometry (LC-MS) method
|
Baseline and after completed each intervention (3 months)
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in Body mass index after each intervention with tomato paste and the control intervention.
Time Frame: Baseline and after completed each intervention (3 months)
|
Body mass index (kg/m^2) will be calculated after measuring weight (kg) and height (meters).
|
Baseline and after completed each intervention (3 months)
|
|
Changes in waist-to-hip ratio with tomato paste and the control intervention.
Time Frame: Baseline and after completed each intervention (3 months)
|
Waist and hip circumferences (cm) will be measured in triplicate and then combined to report waist-to-hip ratio.
|
Baseline and after completed each intervention (3 months)
|
|
Changes in anthropometric measurements after each intervention with tomato paste and the control intervention.
Time Frame: Baseline and after completed each intervention (3 months)
|
Body mass index (kg/m^2) will be calculated after measure weight (kg) and height (meters).
To evaluate waist-to-hip ratio, waist and hip circumferences (cm) will be measured in triplicate.
|
Baseline and after completed each intervention (3 months)
|
|
Changes in body composition after each intervention with tomato paste and the control intervention.
Time Frame: Baseline and after completed each intervention (3 months)
|
Body fat percentage will be measured using a bioelectrical impedance analysis monitor.
|
Baseline and after completed each intervention (3 months)
|
|
Changes in blood pressure after each intervention with tomato paste and the control intervention.
Time Frame: Baseline and after completed each intervention (3 months)
|
Diastolic and systolic blood pressure will be measured by a blood pressure monitor in triplicate.
|
Baseline and after completed each intervention (3 months)
|
|
Changes in heart rate after each intervention with tomato paste and the control intervention.
Time Frame: Baseline and after completed each intervention (3 months)
|
Heart rate (bpm) will be measured with an automatic monitor in triplicate.
|
Baseline and after completed each intervention (3 months)
|
|
Changes in lipidic profile after each intervention with tomato paste and the control intervention.
Time Frame: Baseline and after completed each intervention (3 months)
|
Total cholesterol, HDL-cholesterol, LDL-cholesterol and triglycerides (mg/dL) will be measured by molecular absorption spectrometry.
|
Baseline and after completed each intervention (3 months)
|
|
Changes in liver function after each intervention with tomato paste and the control intervention.
Time Frame: Baseline and after completed each intervention (3 months)
|
Alanine transaminase (ALT), aspartate transaminase (AST), alkaline phosphatase (ALP) and albumin will be assayed by immunoenzymatic methods.
|
Baseline and after completed each intervention (3 months)
|
|
Changes in glucose after each intervention with tomato paste and the control intervention.
Time Frame: Baseline and after completed each intervention (3 months)
|
Glucose (mg/dL) will be measured by molecular absorption spectrometry.
|
Baseline and after completed each intervention (3 months)
|
|
Changes in pro- and anti-inflammatory biomarkers after each intervention with tomato paste and the control intervention.
Time Frame: Baseline and after completed each intervention (3 months)
|
Cytokines (pg/mL), tumor necrosis factor α (TNF-α) (pg/mL) and C-reactive protein (CRP) (mg/dL) will be assayed by immunoenzymatic methods.
|
Baseline and after completed each intervention (3 months)
|
|
Changes in nutrients and energy intake after each intervention with tomato paste and the control intervention.
Time Frame: Baseline and after completed each intervention (3 months)
|
A 7-day food recall will be used.
The data will be analyzed using a software called Programa de Càlcul Nutricional Professional (PCN Pro).
|
Baseline and after completed each intervention (3 months)
|
|
Changes in quality of the diet after each intervention with tomato paste and the control intervention.
Time Frame: Baseline
|
Participants will fill the validated questionnaire measuring adherence to the Mediterranean diet.
|
Baseline
|
|
Changes in physical activity after each intervention with tomato paste and the control intervention.
Time Frame: Baseline and after completed each intervention (3 months)
|
Physical activity will be assessed with the ActiGraph® wGT3X-BT accelerometer.
|
Baseline and after completed each intervention (3 months)
|
|
Changes in sleep quality after each intervention with tomato paste and the control intervention.
Time Frame: Baseline and after completed each intervention (3 months)
|
Sleep quality will be assessed with the ActiGraph® wGT3X-BT accelerometer.
|
Baseline and after completed each intervention (3 months)
|
|
Changes in quality of life after each intervention with tomato paste and the control intervention.
Time Frame: Baseline and after completed each intervention (3 months)
|
Quality of life will be assessed with the WHOQOL-BREF.
|
Baseline and after completed each intervention (3 months)
|
|
Sensory threshold and organoleptic analysis
Time Frame: Baseline
|
The recognition threshold of the five basic tastes will be determined through a classical sensory analysis test, employing a battery of solutions containing the molecules of interest.
This test will include an organoleptic analysis of tomato paste to evaluate its aroma, taste (including acidity, sweetness, saltiness, umami), and hedonic sensation.
|
Baseline
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Rosa M Lamuela Raventós, PhD, University of Barcelona
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Estimated)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
Other Study ID Numbers
- PID2020-114022RB-I00
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.